Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28501 - 28525 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	LOX	4015	downregulated	Cytarabine results in decreased expression of LOX mRNA	5q23.1	A21886
Cytarabine	Approved Investigational	LOXL4	84171	downregulated	Cytarabine results in decreased expression of LOXL4 mRNA	10q24.2	A21886
Cytarabine	Approved Investigational	LRBA	987	downregulated	Cytarabine results in decreased expression of LRBA mRNA	4q31.3	A21886
Cytarabine	Approved Investigational	LRFN5	145581	downregulated	Cytarabine results in decreased expression of LRFN5 mRNA	14q21.1	A21886
Cytarabine	Approved Investigational	LRIG1	26018	upregulated	Cytarabine results in increased expression of LRIG1 mRNA	3p14.1	A21886
Cytarabine	Approved Investigational	LRP1B	53353	downregulated	Cytarabine results in decreased expression of LRP1B mRNA	2q22.1-q22.2	A21886
Cytarabine	Approved Investigational	LRRC32	2615	downregulated	Cytarabine results in decreased expression of LRRC32 mRNA	11q13.5	A21886
Cytarabine	Approved Investigational	LRRC41	10489	downregulated	Cytarabine results in decreased expression of LRRC41 mRNA	1p34.1-p33	A21886
Cytarabine	Approved Investigational	LRRN2	10446	downregulated	Cytarabine results in decreased expression of LRRN2 mRNA	1q32.1	A21886
Cytarabine	Approved Investigational	LRRN3	54674	upregulated	Cytarabine results in increased expression of LRRN3 mRNA	7q31.1	A21886
Cytarabine	Approved Investigational	LRRN4	164312	downregulated	Cytarabine results in decreased expression of LRRN4 mRNA	20p12.3	A21886
Cytarabine	Approved Investigational	LUM	4060	downregulated	Cytarabine results in decreased expression of LUM mRNA	12q21.33	A21886
Cytarabine	Approved Investigational	LY6H	4062	downregulated	Cytarabine results in decreased expression of LY6H mRNA	8q24.3	A21886
Cytarabine	Approved Investigational	LY75	4065	upregulated	Cytarabine results in increased expression of LY75 mRNA	2q24.2	A20985
Cytarabine	Approved Investigational	LYN	4067	downregulated	Cytarabine results in decreased expression of LYN mRNA	8q12.1	A21886
Cytarabine	Approved Investigational	LYZ	4069	upregulated	Cytarabine results in increased expression of LYZ mRNA	12q15	A20985
Cytarabine	Approved Investigational	MAB21L2	10586	downregulated	Cytarabine results in decreased expression of MAB21L2 mRNA	4q31.3	A21886
Cytarabine	Approved Investigational	MAGI1	9223	upregulated	Cytarabine results in increased expression of MAGI1 mRNA	3p14.1	A21886
Cytarabine	Approved Investigational	MAP2	4133	upregulated	Cytarabine results in increased expression of MAP2 mRNA	2q34	A21886
Cytarabine	Approved Investigational	MATN2	4147	downregulated	Cytarabine results in decreased expression of MATN2 mRNA	8q22.1-q22.2	A21886
Cytarabine	Approved Investigational	MBTD1	54799	upregulated	Cytarabine results in increased expression of MBTD1 mRNA	17q21.33	A21886
Cytarabine	Approved Investigational	MCOLN3	55283	downregulated	Cytarabine results in decreased expression of MCOLN3 mRNA	1p22.3	A21886
Cytarabine	Approved Investigational	MDK	4192	downregulated	Cytarabine results in decreased expression of MDK mRNA	11p11.2	A21886
Cytarabine	Approved Investigational	MED9	55090	downregulated	Cytarabine results in decreased expression of MED9 mRNA	17p11.2	A20985
Cytarabine	Approved Investigational	MEGF10	84466	upregulated	Cytarabine results in increased expression of MEGF10 mRNA	5q23.2	A21886

Displaying entries 28501 - 28525 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability